These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

408 related items for PubMed ID: 8524852

  • 1. Topoisomerase IV is a target of quinolones in Escherichia coli.
    Khodursky AB, Zechiedrich EL, Cozzarelli NR.
    Proc Natl Acad Sci U S A; 1995 Dec 05; 92(25):11801-5. PubMed ID: 8524852
    [Abstract] [Full Text] [Related]

  • 2. The mechanism of inhibition of topoisomerase IV by quinolone antibacterials.
    Khodursky AB, Cozzarelli NR.
    J Biol Chem; 1998 Oct 16; 273(42):27668-77. PubMed ID: 9765303
    [Abstract] [Full Text] [Related]

  • 3. Topoisomerase IV, not gyrase, decatenates products of site-specific recombination in Escherichia coli.
    Zechiedrich EL, Khodursky AB, Cozzarelli NR.
    Genes Dev; 1997 Oct 01; 11(19):2580-92. PubMed ID: 9334322
    [Abstract] [Full Text] [Related]

  • 4. DNA gyrase and topoisomerase IV on the bacterial chromosome: quinolone-induced DNA cleavage.
    Chen CR, Malik M, Snyder M, Drlica K.
    J Mol Biol; 1996 May 17; 258(4):627-37. PubMed ID: 8636997
    [Abstract] [Full Text] [Related]

  • 5. Roles of topoisomerase IV and DNA gyrase in DNA unlinking during replication in Escherichia coli.
    Zechiedrich EL, Cozzarelli NR.
    Genes Dev; 1995 Nov 15; 9(22):2859-69. PubMed ID: 7590259
    [Abstract] [Full Text] [Related]

  • 6. Analysis of topoisomerase function in bacterial replication fork movement: use of DNA microarrays.
    Khodursky AB, Peter BJ, Schmid MB, DeRisi J, Botstein D, Brown PO, Cozzarelli NR.
    Proc Natl Acad Sci U S A; 2000 Aug 15; 97(17):9419-24. PubMed ID: 10944214
    [Abstract] [Full Text] [Related]

  • 7. Distribution of gyrase and topoisomerase IV on bacterial nucleoid: implications for nucleoid organization.
    Hsu YH, Chung MW, Li TK.
    Nucleic Acids Res; 2006 Aug 15; 34(10):3128-38. PubMed ID: 16757578
    [Abstract] [Full Text] [Related]

  • 8. Dual targeting of topoisomerase IV and gyrase to reduce mutant selection: direct testing of the paradigm by using WCK-1734, a new fluoroquinolone, and ciprofloxacin.
    Strahilevitz J, Hooper DC.
    Antimicrob Agents Chemother; 2005 May 15; 49(5):1949-56. PubMed ID: 15855518
    [Abstract] [Full Text] [Related]

  • 9. Isolation and quantitation of topoisomerase complexes accumulated on Escherichia coli chromosomal DNA.
    Aedo S, Tse-Dinh YC.
    Antimicrob Agents Chemother; 2012 Nov 15; 56(11):5458-64. PubMed ID: 22869559
    [Abstract] [Full Text] [Related]

  • 10. Analysis of mutational patterns in quinolone resistance-determining regions of GyrA and ParC of clinical isolates.
    Ostrer L, Khodursky RF, Johnson JR, Hiasa H, Khodursky A.
    Int J Antimicrob Agents; 2019 Mar 15; 53(3):318-324. PubMed ID: 30582984
    [Abstract] [Full Text] [Related]

  • 11. Alteration of Escherichia coli topoisomerase IV to novobiocin resistance.
    Hardy CD, Cozzarelli NR.
    Antimicrob Agents Chemother; 2003 Mar 15; 47(3):941-7. PubMed ID: 12604525
    [Abstract] [Full Text] [Related]

  • 12. Contribution of mutations in DNA gyrase and topoisomerase IV genes to ciprofloxacin resistance in Escherichia coli clinical isolates.
    Bansal S, Tandon V.
    Int J Antimicrob Agents; 2011 Mar 15; 37(3):253-5. PubMed ID: 21236644
    [Abstract] [Full Text] [Related]

  • 13. Contrasting enzymatic activities of topoisomerase IV and DNA gyrase from Escherichia coli.
    Ullsperger C, Cozzarelli NR.
    J Biol Chem; 1996 Dec 06; 271(49):31549-55. PubMed ID: 8940171
    [Abstract] [Full Text] [Related]

  • 14. Probing the differential interactions of quinazolinedione PD 0305970 and quinolones with gyrase and topoisomerase IV.
    Pan XS, Gould KA, Fisher LM.
    Antimicrob Agents Chemother; 2009 Sep 06; 53(9):3822-31. PubMed ID: 19564360
    [Abstract] [Full Text] [Related]

  • 15. DNA gyrase, topoisomerase IV, and the 4-quinolones.
    Drlica K, Zhao X.
    Microbiol Mol Biol Rev; 1997 Sep 06; 61(3):377-92. PubMed ID: 9293187
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Mechanisms of action of and resistance to ciprofloxacin.
    Hooper DC, Wolfson JS, Ng EY, Swartz MN.
    Am J Med; 1987 Apr 27; 82(4A):12-20. PubMed ID: 3034057
    [Abstract] [Full Text] [Related]

  • 18. Mechanism of plasmid-mediated quinolone resistance.
    Tran JH, Jacoby GA.
    Proc Natl Acad Sci U S A; 2002 Apr 16; 99(8):5638-42. PubMed ID: 11943863
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Sitafloxacin: antimicrobial activity against ciprofloxacin-selected laboratory mutants of Mycoplasma genitalium and inhibitory activity against its DNA gyrase and topoisomerase IV.
    Deguchi T, Kikuchi M, Yasuda M, Ito S.
    J Infect Chemother; 2015 Jan 16; 21(1):74-5. PubMed ID: 25245990
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.